Latest Capital Raises News

5E Advanced Materials has filed a Form S-1 registration with the SEC to raise up to $30 million through a common stock offering, aiming to advance its Fort Cady boron and lithium project. The capital raise is critical as the company navigates development milestones and financial challenges.

Emyria Limited has reported strong quarterly revenue growth driven by the expansion of its Empax clinic network across multiple Australian states, supported by a recent $8 million institutional placement to fund its national rollout and workforce expansion.

Alliance Nickel reported a $769,000 placement and a $422,000 R&D tax refund while progressing its NiWest Nickel-Cobalt Project, despite renegotiating its Stellantis offtake agreement due to market shifts.

Radiopharm Theranostics has reported promising interim results from its Phase 2b trial of RAD 101, showing high concordance with MRI in brain metastases patients, while progressing multiple other clinical programs and securing a strong cash position to fund operations into 2027.

AUB Group has successfully raised AUD 400 million through an institutional placement to fund its acquisition of Prestige and support future growth. A complementary AUD 40 million Share Purchase Plan will also be offered to eligible shareholders.

Vection Technologies has reported a remarkable quarter with a 250% jump in customer cash receipts and a landmark $7.8 million Defence order, signalling a new phase of growth and operational strength.

Peel Mining Limited has successfully raised $21.25 million to fund accelerated exploration, reporting significant gold intercepts at its Nombinnie Prospect and initiating a major drilling campaign at the Southern Nights Complex.

Eden Innovations has significantly reduced its debt burden and secured fresh capital, while expanding sales and trials of its advanced concrete additives across key international markets.

SSH Group Ltd reported a robust December quarter with a 31% revenue increase, driven by strong mining and hire division performances. The company advanced its Wagtail Gold Deposit development and secured a $2.53 million strategic placement with Xinhai Mining Services, positioning itself for growth in 2026.

Way2VAT Ltd has reported a record quarterly revenue of A$2.13 million for Q4 FY25, driven by strong client growth and strategic acquisitions, setting the stage for further expansion in 2026.

Epiminder Limited has successfully listed on the ASX, raising $125 million to commercialise its FDA-approved Minder device. The company has initiated the first US implant and secured five leading medical centres for its DETECT study.

Algorae Pharmaceuticals has advanced its AI drug discovery capabilities with the launch of AlgoraeOS v2 and secured key commercial partnerships, including a $3 million debt facility to support expansion in Australia and New Zealand.